Please login to the form below

Not currently logged in
Email:
Password:

hepatitis B

This page shows the latest hepatitis B news and features for those working in and with pharma, biotech and healthcare.

First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India

First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India

The vaccine candidate was developed using SpyBiotech’s SpyCatcher/SpyTag protein “superglue” technology and a virus-like particle (VLP) from the Hepatitis B antigen as a carrier. ... VLPs are already licensed for use in vaccines against Hepatitis B,

Latest news

More from news
Approximately 9 fully matching, plus 85 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    hepatitis B virus (HBV). Strategic. collaboration ‐. development. $445m. Innate Pharma/. ... Manufacture and supply of CAR‐T cell therapy, Kymriah, for B‐cell acute lymphoblastic leukaemia.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8  to 12-week course. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the

  • Pharma deals in April 2015 Pharma deals in April 2015

    its SAR3419, an antibody-drug conjugate designed to treat diffuse large B-cell lymphoma (DLBCL) and other blood cancers. ... These are key markets for this product as more than 75% of all HCC cases occur in the APAC region, largely in association with

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Corporate acquisition. 545. Cytos Biotechnology/ OnCore. Access to virus like particle (VLP) platform for the treatment and prevention of hepatitis B with an option to other viral diseases.

  • Deal Watch table for September 2014 Deal Watch table for September 2014

    153. NeuroVive / OnCore. Licence and collaboration. NVP018 an oral sangamide-based 2nd generation cyclophilin inhibitor for hepatitis B.

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • UK vs US: what makes a successful immunisation programme?

    My challenge started when my daughter Anna was born. The Hepatitis B vaccine is given at birth in the US, and at the time, this was not a part of the ... The Meningitis B vaccine is unique to the UK and since we live in the UK that was easy to get.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics